Back to tenders & grants page
RFP 2022.03 - Supporting the use of TRIPS Flexibilities: Joint Portfolio End-of-Project Evaluation Pharmaceutical & Medical, Manufacturing RFP 2022.03 - Supporting the use of TRIPS Flexibilities: Joint Portfolio End-of-Project Evaluation
Receive Tenders like this by email

RFP 2022.03 - Supporting the use of TRIPS Flexibilities: Joint Portfolio End-of-Project Evaluation

RFP 2022.03 - Supporting the use of TRIPS Flexibilities: Joint Portfolio End-of-Project Evaluation has been closed on 23 Feb 2022. It no longer accepts any bids. For further information, you can contact the United Nations Capital Development Fund

Bellow, you can find more information about this project: 

Location: Switzerland

General information

Donor:

United Nations Capital Development Fund

Industry:

Pharmaceutical & Medical

Manufacturing

Status:

Closed

Timeline

Published:

26 Jan 2022

Deadline:

23 Feb 2022

Value:

Not available

Contacts

Description

https://www.ungm.org/Public/Notice/165517
Description
************************************************************************************************************** In order to access the RFP documents, please log-in as a registered Supplier (Account registration accessible on https://www.ungm.org/Account/Registration). If you experience difficulties in accessing the RFP documents after having registered and expressed interest, please send an email to: [email protected]. ************************************************************************************************************** The purpose of this RFP is to seek qualified firm to carry out joint end-of-project evaluations for three Unitaid projects related to Intellectual Property: Supporting the use of TRIPS Flexibilities. 1) “Expanding the use of TRIPS flexibilities to promote affordable access to medicines,” implemented by South Centre (SC). 2) “Use of TRIPS flexibilities to increase affordability of treatment for HIV, TB and hepatitis C virus in middle-income countries”, implemented by International Treatment Preparedness Coalition (ITPC). 3) “Health for all: Increasing access to HIV, TB and Hepatitis C treatment through effective use of TRIPS flexibilities”, implemented by Third World Network Berhad (TWN). Bidders are invited to submit a proposal for the above mentioned Request for Proposal in accordance to the documents attached in the "Tender Document" tab. Kindly pay attention to below tender timeline: 1. No later than 21 February 2022 17h00 Geneva time, bidder shall complete and return, under “Correspondence” tab of UNGM (paragraph 4.2 of the Request for Proposals refer): a) Acknowledgement Form (Annex 1 of the Request for Proposals) duly completed and signed as confirmation of bidder's intention to submit a bona fide proposal and designate the bidder's representative to whom communications may be directed, including any addenda; and b) Confidentiality Undertaking form (Annex 2 of the Request for Proposals) signed. 2) A prospective bidder requiring any clarification on technical, contractual or commercial matters may submit its questions via UNGM “Correspondence” tab no later than 21 February 2022 17h00 Geneva time and formulate them as follows: Question # | Reference to RFP (paragraph #) | Question text The Unitaid team will respond in writing (via the “Correspondence” tab of UNGM) to any request for clarification of the RFP that it receives prior to the date mentioned in the Request for Proposals, paragraph 4.6. A consolidated document of Unitaid’s response to all questions (including an explanation of the query but without identifying the source of enquiry) will be published on the UNGM. Paragraph 4.6 of the Request for Proposals refer. 3) Proposals must be submitted and uploaded via UNGM, “Tender Documents” tab no later than 23 February 2022 at 17:00 hours, Geneva time (paragraph 4.11 of the Request for Proposals refer). Unitaid recognizes climate change as a global emergency and threat to the achievement of the Sustainable Development Goals (SDG). On 11 November 2021 Unitaid launched its Climate Action Roadmap committing to reduce carbon emissions of the Secretariat by 50% by 2030 and offset its carbon footprint to effectively achieve net-zero emissions from 2022. In line with Unitaid’s effort in reducing carbon footprints related to the procurement activities, it is highly preferred that the bidders have a regional/local presence or have access to local counterparts to minimize the need for international travel. ************************************************************************************************************** Objective of the consultancy: The Evaluators are expected to support Unitaid with the assessment of the relevance, coherence, efficiency, effectiveness, impact, sustainability and lessons learned for three (3) projects as captured by the outcome, outputs and activities performed. The grant evaluation is an assessment of both Unitaid and the grantees’ performance. Qualification of Firm and Consultants: The successful bidders will propose a multi-disciplinary team of 3-4 experienced evaluators, including the team leader. The team leader must have at least 10 years of experience leading evaluations of a similar scope and complexity and a strong understanding of the Intellectual Property Rights (IPR) landscape in the public health context, and notably with regards to IPR and access to medicines. Core team members should have at least 5 years of individual experience in their respective areas of technical expertise. The proposed evaluation team should meet the following requirements: • Knowledge of TRIPS flexibilities as applied to access to medicines; • Knowledge of or familiarity with the challenges related to access to innovative medicines in LMICs; • Demonstrable knowledge of or familiarity with the issues, sensitivities and global debates on IPR and access to medicines in developing countries in general, and access to HIV, TB and HCV medicines in particular; • Demonstrable experience or knowledge of the actual implementation of TRIPS flexibilities in the context of facilitating access to medicines in countries would be an asset. • Experience in the monitoring and evaluation of advocacy trainings and assessing impact of trainings through post training surveys • At least one team member with expertise in collection and analysis of qualitative data; • At least one team member with expertise in quantitative assessment of public health and economic impact; • Proficiency in English (knowledge of other UN languages an asset) and proficiency in other UN languages (such as Spanish, Portuguese, Russian, Arabic, etc) is desirable; final deliverables must be submitted in English

Get free access to our Tenders & Grants Database

Our service is free of charge and will always be

Join Now

Donors

Find out more